apnea has been researched along with Neuroleptic Malignant Syndrome in 2 studies
Apnea: A transient absence of spontaneous respiration.
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greenwood, M | 1 |
Meechan, JG | 1 |
Shintani, S | 1 |
Shiigai, T | 1 |
Tsuchiya, K | 1 |
Kikuchi, M | 1 |
2 other studies available for apnea and Neuroleptic Malignant Syndrome
Article | Year |
---|---|
General medicine and surgery for dental practitioners. Part 2--metabolic disorders.
Topics: Amyloidosis; Anesthetics, Local; Apnea; Carbohydrate Metabolism, Inborn Errors; Dental Care for Chro | 2010 |
Hyperventilation alternating with apnea in neuroleptic malignant syndrome associated with metoclopramide and cisapride.
Topics: Aged; Apnea; Brain; Cisapride; Fatal Outcome; Humans; Hyperventilation; Male; Metoclopramide; Neurol | 1995 |